Article Information
History
- March 21, 2024.
Article Versions
- Version 1 (July 23, 2023 - 09:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Abdollah Safari, PhDa,
- Hamed Helisaz, PhDb,c,
- Shahrzad Salmasi, PhDd,
- Adenike Adelakun, MSce,
- Mary A. De Vera, PhDe,f,
- Jason G. Andrade, MDg,h,i,k,
- Marc W. Deyell, MD MScg,i,j and
- Peter Loewen, PharmDe,f,i,*
- aSchool of Mathematics, Statistics, and Computer Science, College of Science, University of Tehran, Iran
- bFaculty of Applied Science, University of British Columbia
- cGranTAZ Consulting Ltd., Vancouver, Canada
- dMcGill University, Montreal, Canada
- eFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada
- fCollaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Canada
- gDivision of Cardiology, Faculty of Medicine, University of British Columbia, Vancouver, Canada
- hAtrial Fibrillation Clinic, Vancouver General Hospital, Canada
- iUBC Center for Cardiovascular Innovation, Vancouver, Canada
- jCentre for Health Evaluation & Outcome Sciences, Providence Health Care Research Institute, Canada
- kMontreal Heart Institute, Université de Montréal, Montréal, Canada
- ↵*Address for correspondence:
Peter Loewen B.Sc.(Pharm), ACPR, Pharm.D., FCSHP, R.Ph., Associate Professor | Faculty of Pharmaceutical Sciences, David H MacDonald Professor in Clinical Pharmacy, Faculty, UBC Collaboration for Outcomes Research & Evaluation, Researcher, UBC Center for Cardiovascular Innovation, The University of British Columbia | Vancouver Campus, 2405 Wesbrook Mall | Vancouver, BC Canada V6T 1Z3, phone 604 506 8011 | peter.loewen{at}ubc.ca